ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	38/675	73/6030	5.06178499903452e-18	2.38916251954429e-15	2.00872941540633e-15	6356/6357/6362/6347/6364/6368/6369/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3589/3605/3552/3553/3557/11009/90865/3569/4312/4314/5008/5196/6696/8741	38
WP5055	Burn wound healing	44/675	97/6030	1.04329080430836e-17	2.46216629816773e-15	2.07010859591711e-15	8038/6347/57124/1139/1277/1278/2919/3579/1634/2200/2335/10468/3082/3383/3552/3553/3569/3624/3791/3853/3956/23643/407024/4312/4322/4313/79148/4314/100463486/64332/64127/5159/6282/6280/8796/871/6423/6678/7042/7043/7076/7097/51311/3371	44
WP2806	Complement system	36/675	75/6030	1.13086535576727e-15	1.7792281597405e-13	1.49591662850617e-13	133/715/716/717/719/720/722/728/27202/729/1604/22918/629/3075/3426/5199/10332/1380/1634/2214/2219/2357/2769/3383/3673/3687/3690/3915/5648/5329/5806/6401/6403/710/6696/7097	36
WP558	Complement and coagulation cascades	27/675	48/6030	2.9186986689618e-14	3.44406442937492e-12	2.89565631104894e-12	712/713/715/716/717/719/721/728/729/1604/629/3075/3426/1380/2149/2153/2155/3827/5648/5327/5328/5329/5104/5054/710/7056/7450	27
WP5115	Network map of SARS-CoV-2 signaling pathway	56/675	190/6030	2.33469881552272e-12	2.20395568185345e-10	1.85301358621488e-10	350/8542/684/715/716/6356/6347/6364/6348/6351/6355/9332/1051/629/3075/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/2247/2335/3091/10964/2537/8519/10410/3458/3605/8807/3552/3553/90865/3569/3699/116844/64386/114548/5196/5743/6288/6289/6403/5104/5054/6772/7018	56
WP2911	miRNA targets in ECM and membrane receptors	15/675	22/6030	3.77110579698557e-10	2.96660322696198e-08	2.49422260607642e-08	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/22801/3910/3915/7058	15
WP455	GPCRs, class A rhodopsin-like	38/675	118/6030	5.47102816838025e-10	3.68903613639354e-08	3.10162048042008e-08	134/147/187/719/27202/1230/729230/1232/1237/3577/3579/1909/2149/2151/9002/2867/2357/2358/2359/54328/2842/2850/2861/2828/8111/8843/3274/64106/4886/4887/5540/53829/9934/5031/5724/5737/5739/56670	38
WP3624	Lung fibrosis	23/675	52/6030	1.39915416326968e-09	8.25500956329109e-08	6.94054104674563e-08	6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/2247/2252/26585/3082/3553/3569/4313/5155/5328/5806/6696/7015/7076	23
WP545	Complement activation	12/675	18/6030	3.46333969749205e-08	1.68199158417116e-06	1.41416330783347e-06	712/713/715/716/717/720/721/729/1604/629/5199/5648	12
WP5090	Complement system in neuronal development and plasticity	30/675	93/6030	3.56354149188805e-08	1.68199158417116e-06	1.41416330783347e-06	712/713/715/716/717/719/720/721/722/725/728/27202/729/1604/629/3075/3426/5199/10584/1380/6376/2219/8547/3458/3687/3690/5648/710/7042/7043	30
WP2431	Spinal cord injury	30/675	98/6030	1.3402464226174e-07	5.75087555886739e-06	4.83514738111732e-06	199/301/63827/713/6347/729230/1280/1282/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/4321/4843/9423/5743/6098/6403/6869/8741/1462	30
WP2865	IL1 and megakaryocytes in obesity	13/675	23/6030	1.52538378738894e-07	5.99984289706316e-06	5.0444709460143e-06	6347/1232/2149/3383/3458/3553/3554/114548/7941/6280/8991/7076/7097	13
WP5088	Prostaglandin signaling	14/675	28/6030	3.80745392058089e-07	1.38239865424168e-05	1.16227540733522e-05	834/6347/6348/729230/2919/3627/4283/3458/3605/3552/3553/3569/114548/9536	14
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	57/675	265/6030	5.39094530862798e-07	1.81751870405172e-05	1.52811006116748e-05	284/285/1302/1277/1278/1280/1281/1282/1284/1289/1290/50509/1292/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3091/3559/3563/22801/3673/3678/8516/3687/3690/3791/284217/3908/3910/3915/10319/4843/4846/5008/9180/5155/5159/5209/5228/6515/6696/7010/7058/3371/7143/7450	57
WP24	Peptide GPCRs	17/675	41/6030	6.32666833771226e-07	1.99079163693346e-05	1.67379225495966e-05	719/728/1230/729230/1232/1237/3577/3579/1909/2357/2358/2359/4886/4887/5540/6869/7253	17
WP2848	Pluripotent stem cell differentiation pathway	15/675	34/6030	1.12191597444577e-06	3.30965212461502e-05	2.78264685767142e-05	3577/2255/2247/10468/3082/3589/3569/3624/10637/5155/6469/7018/7043/7472/7474	15
WP129	Matrix metalloproteinases	12/675	24/6030	2.6595299429083e-06	7.0900696969362e-05	5.961097849565e-05	4312/4319/4321/4322/4323/4327/4313/64386/79148/4314/4316/7076	12
WP3967	miR-509-3p alteration of YAP1/ECM axis	10/675	17/6030	2.70384013866211e-06	7.0900696969362e-05	5.961097849565e-05	1277/1281/1289/1909/2335/10082/6678/7004/7058/7291	10
WP619	Type II interferon signaling	14/675	34/6030	6.93482337714123e-06	0.000172275612316351	0.000144843679400678	3627/4283/2633/3383/2537/3458/3553/4843/5698/8651/9021/6688/6772/6890	14
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20/675	63/6030	9.12404652985903e-06	0.000215327498104673	0.000181040291671413	6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/84868/8519/3569/5196/6772/7020	20
WP4172	PI3K-Akt signaling pathway	55/675	280/6030	1.57563677953648e-05	0.000354143123781534	0.000297751912724439	284/285/1277/1278/1280/1282/1284/1291/1292/1293/131873/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3559/3563/3569/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/4846/4915/5008/9180/5155/5159/5228/8503/10110/6696/7010/7058/7097/3371/7143/7450	55
WP2328	Allograft rejection	22/675	76/6030	1.73224375331034e-05	0.000371645023437491	0.00031246693540574	23743/712/713/717/720/721/729/1604/941/942/1289/6373/4283/50943/3002/3458/3605/3552/3553/3559/120892/6772	22
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/675	24/6030	2.01930931224487e-05	0.00041439738929547	0.000348411721151633	6348/6351/1230/729230/1232/1437/3458/3595/8809/7042/7043	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/675	17/6030	2.77344997997898e-05	0.000545445162729198	0.000458592387040383	6347/3383/3553/5196/6401/6403/7042/7043/7097	9
WP4754	IL-18 signaling pathway	48/675	239/6030	3.05704923433113e-05	0.000577170895441718	0.000485266341618036	59/11096/6362/6347/6364/6348/6351/1051/9076/1277/1278/1281/2920/2921/2335/2523/338442/3383/3458/10068/8809/8807/3553/3559/3569/81618/4312/4322/4323/4313/4314/4688/4776/64332/4843/51299/7941/5743/5806/9021/6696/6869/7018/7052/7076/7127/79931/80149	48
WP5087	Malignant pleural mesothelioma	68/675	381/6030	4.36005143700068e-05	0.000791517030101661	0.000665481535121156	59/9510/284/285/834/6347/6351/29126/1009/1012/1014/1001/1003/1004/1282/1284/1437/1440/115908/2919/3627/6374/1944/2255/2247/2252/2321/2335/8061/11211/3082/3091/3620/3553/3569/3673/3690/3791/284217/3908/3910/3915/10319/26524/4323/4313/4314/114548/4915/5155/5159/5163/5228/5328/4920/6401/6422/6423/8140/64321/6678/6772/7004/7010/7015/7472/7474/25937	68
WP530	Cytokines and inflammatory response	9/675	19/6030	8.56193126747446e-05	0.00149675242898072	0.00125842030714927	1437/1440/2919/2920/3458/3589/3552/3553/3569	9
WP1533	Vitamin B12 metabolism	13/675	37/6030	0.000106459351222471	0.00179460049203594	0.00150884118085983	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648/6947	13
WP3617	Photodynamic therapy-induced NF-kB survival signaling	12/675	33/6030	0.000134234126980574	0.00218477613568382	0.00183688805341837	597/1437/2920/3383/3552/3553/3569/4312/4313/4314/5743/6401	12
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	18/675	65/6030	0.000187199300720439	0.00290415544359906	0.00244171855985023	947/2354/8456/94234/10468/2619/284110/3458/3488/5653/5650/8549/4488/22822/6275/6422/11005/7474	18
WP2877	Vitamin D receptor pathway	31/675	143/6030	0.000190739022778752	0.00290415544359906	0.00244171855985023	11096/147/768/634/9075/1543/1594/1555/1577/168002/1673/50486/3091/3488/9173/5653/3827/126364/639/5744/6273/6275/6279/6280/6422/219855/6696/79689/7042/7056/54210	31
WP4891	COVID-19 adverse outcome pathway	7/675	13/6030	0.000199756510621832	0.00294640853167202	0.00247724356922469	6347/6348/1440/3627/3553/3559/3569	7
WP2849	Hematopoietic stem cell differentiation	14/675	46/6030	0.000331426120785168	0.00474039784880604	0.00398557089429053	947/1437/1440/2354/2624/3552/3553/3569/3690/4582/4778/861/6688/7068	14
WP474	Endochondral ossification	16/675	57/6030	0.000356575580956569	0.00480867640604288	0.00404297726377825	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP4808	Endochondral ossification with skeletal dysplasias	16/675	57/6030	0.000356575580956569	0.00480867640604288	0.00404297726377825	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	12/675	37/6030	0.000459345631625774	0.00602253161464904	0.00506354687493909	84674/834/50506/3553/4210/4671/58484/91662/114548/64127/639/8767	12
WP15	Selenium micronutrient network	16/675	59/6030	0.000545357440383421	0.00695699221245877	0.00584921066926172	19/247/6347/2155/3383/3458/3553/3569/8942/5327/10549/5743/6288/6289/5054/6648	16
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/675	28/6030	0.000576981107595181	0.00716671270486646	0.00602553677460895	6347/29126/941/942/3627/3559/8651/7042/7043/51311	10
WP5097	CCL18 signaling pathway	12/675	39/6030	0.000785506996395512	0.00950664877688928	0.00799287820893679	59/1237/1278/1437/2335/3091/4313/6615/6772/7004/7020/7291	12
WP306	Focal adhesion	35/675	183/6030	0.000931467088811311	0.0109913116479735	0.00924113401268064	87/1277/1278/1280/1282/1284/1290/50509/1292/2268/2321/2335/3055/3082/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/5155/5159/5228/8503/399694/6696/7058/3371/7143/7450	35
WP453	Inflammatory response pathway	9/675	26/6030	0.00140532046098837	0.0161783233557686	0.0136022031782443	941/942/1277/1278/1281/2335/3458/3559/3915	9
WP4823	Genes controlling nephrogenesis	10/675	32/6030	0.00187263364813009	0.0210448352837477	0.0176938066502518	2296/2737/3237/8516/3791/4868/5155/5159/6092/6469	10
WP5094	Orexin receptor pathway	23/675	112/6030	0.00264939810539662	0.0290817652499349	0.0244509935308329	2920/1846/2354/3091/9456/3383/3553/3569/3777/3908/4023/23764/4322/4314/4846/64106/8013/5069/5163/861/6401/6696/3371	23
WP716	Vitamin A and carotenoid metabolism	10/675	34/6030	0.00309515121434709	0.0332025312084506	0.027915598272939	127/8854/83875/1381/1382/56603/4023/29881/116362/195814	10
WP1539	Angiogenesis	8/675	24/6030	0.00338700030376557	0.03552586985283	0.0298689851349619	284/2247/2321/3091/3791/4846/5155/7010	8
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10/675	35/6030	0.00390826745876919	0.0397304356945782	0.0334040460679214	284/285/597/3091/3485/4843/5743/5054/6515/7043	10
WP272	Blood clotting cascade	6/675	15/6030	0.00395620863907876	0.0397304356945782	0.0334040460679214	2153/2155/5327/5328/5054/7450	6
WP5092	Interactions of natural killer cells in pancreatic cancer	8/675	25/6030	0.00450162270918665	0.0442659566403354	0.0372173631877932	6347/6348/6351/1437/2214/2624/3002/3458	8
WP4496	Signal transduction through IL1R	9/675	31/6030	0.00543319087748497	0.0514363707916017	0.0432460120170247	3552/3553/3554/3556/3557/3569/11213/7042/7043	9
WP176	Folate metabolism	12/675	48/6030	0.00544876809233069	0.0514363707916017	0.0432460120170247	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648	12
WP4493	Cells and molecules involved in local acute inflammatory response 	6/675	16/6030	0.00573947746146444	0.0531183012119846	0.0446601239003528	729/3383/3552/3569/3827/6403	6
WP117	GPCRs, other	10/675	37/6030	0.00603502416259029	0.0547794500912041	0.0460567633460838	27202/3577/3579/1909/2149/11245/53831/59340/53829/5737	10
WP5222	2q13 copy number variation syndrome	12/675	49/6030	0.00650144760551228	0.057899684335883	0.0486801538684832	55289/1437/3552/3553/3554/3556/8808/3557/3569/8651/9021/6772	12
WP5188	Retinol metabolism	5/675	12/6030	0.0069979327655957	0.0611671160252069	0.0514273031701672	316/1543/1551/10170/195814	5
WP4541	Hippo-Merlin signaling dysregulation	20/675	101/6030	0.00746000450188436	0.0636499272514825	0.0535147693439092	1009/1012/1014/1001/1003/1004/3627/2321/22801/3673/3678/8516/3687/3690/3791/26524/4915/5159/7004/7010	20
WP2197	Endothelin pathways	8/675	27/6030	0.00755168628407419	0.0636499272514825	0.0535147693439092	10203/1909/2769/51764/4846/4886/23236/5739	8
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/675	22/6030	0.00805486577650354	0.0666999411668363	0.0560791209185934	2919/2920/2247/3553/5155/6469/30812	7
WP3937	Microglia pathogen phagocytosis pathway	10/675	39/6030	0.00896901509225242	0.0717521207380193	0.0603268276499404	712/713/2207/2209/3055/4688/8503/54210/54209/7305	10
WP4329	miRNAs involvement in the immune response in sepsis	10/675	39/6030	0.00896901509225242	0.0717521207380193	0.0603268276499404	6348/6351/3002/3383/3552/3569/3934/407008/407024/51311	10
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	12/675	52/6030	0.010643803423202	0.0837312535958555	0.0703984893078446	1003/1277/1278/2321/3082/3791/4313/8829/91584/6615/7042/7043	12
WP5198	Inflammatory bowel disease signaling	9/675	35/6030	0.0126681909628662	0.0965463332598093	0.0811729875980109	50943/3458/3595/8807/3552/3569/64127/6772/7097	9
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/675	134/6030	0.0127974104846293	0.0965463332598093	0.0811729875980109	9076/51208/9075/9073/1282/1284/2335/94234/11211/3091/3678/26524/4313/4854/4855/8828/8503/6615/6678/7042/7043/7291/7472/7474	24
WP98	Prostaglandin synthesis and regulation	10/675	41/6030	0.0128864809223898	0.0965463332598093	0.0811729875980109	1645/301/308/1909/3290/9536/5737/5739/5743/6916	10
WP12	Osteoclast signaling	5/675	14/6030	0.0146292056208199	0.104620985651924	0.0879618902559663	1513/8111/3690/5155/6696	5
WP4210	Tryptophan catabolism leading to NAD+ production	5/675	14/6030	0.0146292056208199	0.104620985651924	0.0879618902559663	3620/8942/10135/23057/6999	5
WP5063	FOXP3 in COVID-19	5/675	14/6030	0.0146292056208199	0.104620985651924	0.0879618902559663	941/942/50943/3559/3569	5
WP5083	Neuroinflammation and glutamatergic signaling	21/675	115/6030	0.0155355424137688	0.109444418198491	0.0920172739982849	816/1610/2247/2898/2906/116443/3458/3552/3553/3554/3569/80131/23236/29968/6507/6515/92745/9021/6772/7042/7043	21
WP3929	Chemokine signaling pathway	26/675	152/6030	0.0174049110944535	0.1208105593615	0.101573552362368	6356/6364/6369/6348/6351/1230/729230/1232/1237/6376/3627/6373/2921/6374/4283/3579/2268/59345/2791/51764/3055/5196/8503/23236/399694/6772	26
WP2406	Cardiac progenitor differentiation	8/675	31/6030	0.0179641892068051	0.122885468197275	0.103318067596728	2247/2626/3624/3791/3084/4920/64321/7070	8
WP1992	Genes targeted by miRNAs in adipocytes	4/675	10/6030	0.0188014200621614	0.126775289562003	0.106588501705787	2078/2697/9464/3759	4
WP727	Monoamine transport	6/675	21/6030	0.0239309479060923	0.159090245234867	0.133757855605586	273/3553/3554/3690/6853/6999	6
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	7/675	27/6030	0.0256030585748349	0.164157692156017	0.138018398623591	6347/2977/3553/3569/4312/4314/23657	7
WP5218	Extrafollicular B cell activation by SARS-CoV-2	13/675	65/6030	0.025866773780478	0.164157692156017	0.138018398623591	57379/60468/720/941/1380/8519/3458/3569/3687/639/57823/8741/7494	13
WP465	Tryptophan metabolism	8/675	33/6030	0.0259004177960703	0.164157692156017	0.138018398623591	8854/316/1543/1545/9420/3620/8942/6999	8
WP3413	NOTCH1 regulation of endothelial cell calcification	5/675	16/6030	0.026432170770884	0.164157692156017	0.138018398623591	249/813/2702/4256/5327	5
WP4478	LTF danger signal response pathway	5/675	16/6030	0.026432170770884	0.164157692156017	0.138018398623591	3552/3553/3569/7097/54210	5
WP4707	Aspirin and miRNAs	4/675	11/6030	0.0269788130223397	0.165376620084991	0.139043233211512	283120/4846/5163/5743	4
WP4747	Netrin-UNC5B signaling pathway	10/675	46/6030	0.0281522028230178	0.17035691964698	0.143230505590792	249/6347/1003/1277/3383/3552/3791/9423/54538/6401	10
WP3941	Oxidative damage response	9/675	40/6030	0.0296171494660962	0.176953095544271	0.148776353747079	712/713/715/716/717/719/721/728/1380	9
WP4008	NO/cGMP/PKG mediated neuroprotection	8/675	34/6030	0.0306649650549627	0.18092329382428	0.152114366127907	816/1261/2906/2977/3458/3553/4843/4846	8
WP289	Myometrial relaxation and contraction pathways	22/675	131/6030	0.0328412499643194	0.191371234359985	0.160898651547088	59/133/816/2697/59345/2791/51764/2981/3485/3488/3553/3569/23764/4846/5142/5333/10266/10268/64407/5999/8490/8787	22
WP3287	Overview of nanoparticle effects	5/675	17/6030	0.0340935825493412	0.193881577870952	0.163009265961974	1001/1282/2335/3569/5743	5
WP4830	GDNF/RET signaling axis	5/675	17/6030	0.0340935825493412	0.193881577870952	0.163009265961974	2296/2737/26585/6092/64321	5
WP3527	Pre-implantation embryo	8/675	35/6030	0.0359973425637322	0.198289630535636	0.166715411935626	366/55509/2354/94234/2624/4603/30812/7004	8
WP4136	Fibrin complement receptor 3 signaling pathway	8/675	35/6030	0.0359973425637322	0.198289630535636	0.166715411935626	6347/3627/2921/3569/23643/4843/5327/7305	8
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	13/675	68/6030	0.0362278395154135	0.198289630535636	0.166715411935626	816/6347/1594/1673/10964/3458/3569/64127/23236/5333/6772/7097/51311	13
WP4538	Regulatory circuits of the STAT3 signaling pathway	14/675	75/6030	0.0366083499554404	0.198289630535636	0.166715411935626	1271/1438/1439/1441/2149/2151/9002/3595/3601/3559/3563/9180/5159/9021	14
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/675	12/6030	0.0369692531507118	0.198289630535636	0.166715411935626	2099/2335/8061/7076	4
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/675	18/6030	0.0429960079769281	0.225490175167889	0.189584736927507	308/1280/2252/2335/3490	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/675	18/6030	0.0429960079769281	0.225490175167889	0.189584736927507	1014/1004/2335/6615/3371	5
WP75	Toll-like receptor signaling pathway	15/675	84/6030	0.0442637200174328	0.229587646683827	0.193029756467	6348/6351/941/942/3627/6373/4283/3553/3569/23643/8503/6696/6772/7097/51311	15
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	21/675	128/6030	0.0454853298368303	0.233359518293303	0.196201022293879	116/720/721/1051/1103/1139/2328/2624/2697/3091/3359/3552/3553/3557/3569/3764/4915/6507/6869/7018/7068	21
WP4331	Neovascularisation processes	8/675	37/6030	0.0484566816199129	0.242481852039511	0.203870781041248	284/3091/3791/4854/4855/5155/7042/7043	8
WP4723	Omega-3 / omega-6 fatty acid synthesis	4/675	13/6030	0.0488046100503252	0.242481852039511	0.203870781041248	2180/2182/54898/3992	4
WP4724	Omega-9 fatty acid synthesis	4/675	13/6030	0.0488046100503252	0.242481852039511	0.203870781041248	2180/2182/54898/3992	4
WP4969	RAS and bradykinin pathways in COVID-19	6/675	25/6030	0.0532314926141236	0.261721505352774	0.220046849950927	3552/3553/3827/4846/5054/710	6
WP43	Oxidation by cytochrome P450	8/675	38/6030	0.0556199915929302	0.270645732287248	0.227550046994408	1543/1545/56603/1594/1555/1577/1551/9420	8
WP3971	OSX and miRNAs in tooth development	4/675	14/6030	0.0624747718221272	0.300898901020858	0.252985918119677	249/407024/4854/4855	4
WP5053	Development of ureteric collection system	10/675	53/6030	0.0664637705622882	0.316877774802021	0.266420430643091	2296/80144/341640/10468/2737/3237/8516/6092/6469/7042	10
WP5122	Prostaglandin and leukotriene metabolism in senescence 	6/675	27/6030	0.0735871498410078	0.344868123607445	0.289953797056215	247/3488/23236/9536/5743/6916	6
WP4816	TGF-beta receptor signaling in skeletal dysplasias	10/675	54/6030	0.0737959332295591	0.344868123607445	0.289953797056215	25805/2022/2200/10468/3458/3624/10637/5054/6696/6772	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	4/675	15/6030	0.0779326146259225	0.356399216922901	0.299648761775053	19/9388/4023/255738	4
WP5174	Ulcerative colitis signaling	4/675	15/6030	0.0779326146259225	0.356399216922901	0.299648761775053	50943/3458/64127/7097	4
WP1591	Heart development	7/675	34/6030	0.0785286410169105	0.356399216922901	0.299648761775053	2255/2296/2626/9464/23493/4776/6469	7
WP4540	Hippo signaling regulation pathways	14/675	84/6030	0.0818400545579867	0.367890530965426	0.309310281387078	1009/1012/1014/1001/1003/1004/2321/3791/26524/4915/5159/23236/7004/7010	14
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	6/675	28/6030	0.0852152968045154	0.379449246148408	0.319028469665365	9509/1277/1278/60681/4015/871	6
WP236	Adipogenesis	18/675	115/6030	0.0877284223516876	0.386988928504641	0.325367587079058	1051/1271/56603/2624/2626/3091/3569/4023/10135/5008/5346/5054/8651/9021/6695/6772/7291/25937	18
WP2371	Parkinson's disease pathway	7/675	35/6030	0.0891614656302052	0.389668627569045	0.327620590083697	2861/120892/100506755/6622/9627/9246/7345	7
WP1423	Ganglio sphingolipid metabolism	3/675	10/6030	0.0920572319970921	0.398633151400252	0.335157667435092	8708/2523/30815	3
WP247	Small ligand GPCRs	4/675	16/6030	0.0950994292442686	0.404386762191845	0.339995114510093	5724/5737/5739/9294	4
WP516	Hypertrophy model	4/675	16/6030	0.0950994292442686	0.404386762191845	0.339995114510093	3458/3552/3554/8013	4
WP2374	Oncostatin M signaling pathway	11/675	64/6030	0.0965437441108303	0.406862921609928	0.34207698806187	6347/1051/3091/4312/4322/4314/5008/9180/5054/9021/6772	11
WP560	TGF-beta receptor signaling	9/675	50/6030	0.100355946417825	0.419185900081536	0.352437743824128	25805/2022/10468/3458/3624/10637/5054/6696/6772	9
WP2880	Glucocorticoid receptor pathway	11/675	65/6030	0.105121854571837	0.433067664176116	0.364109075366627	6347/6364/3589/89795/5142/5743/5272/1836/5552/7056/84951	11
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/675	23/6030	0.106431883568706	0.433067664176116	0.364109075366627	285/2022/2200/10631/5054	5
WP3893	Development and heterogeneity of the ILC family	5/675	23/6030	0.106431883568706	0.433067664176116	0.364109075366627	3458/3605/3553/90865/3569	5
WP3874	Canonical and non-canonical TGF-B signaling	4/675	17/6030	0.113870458996554	0.45165425753255	0.379736072903148	26585/4015/4016/4017	4
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	4/675	17/6030	0.113870458996554	0.45165425753255	0.379736072903148	249/1594/6098/6696	4
WP691	Tamoxifen metabolism	4/675	17/6030	0.113870458996554	0.45165425753255	0.379736072903148	1543/1545/1577/2328	4
WP3630	NAD metabolism, sirtuins and aging	3/675	11/6030	0.116461639112624	0.454296641827757	0.381957702874809	3091/10135/6098	3
WP5052	Nephrogenesis	3/675	11/6030	0.116461639112624	0.454296641827757	0.381957702874809	8854/4211/84870	3
WP2858	Ectoderm differentiation	18/675	120/6030	0.119339072351771	0.461705263524885	0.388186628788764	91653/6347/1004/54898/2737/57476/9687/3853/9079/4061/22871/5783/4920/6469/6622/6781/7020/7022	18
WP5036	Angiotensin II receptor type 1 pathway	5/675	24/6030	0.122728349492428	0.470957568783952	0.395965663317461	59/1277/1278/3091/3589	5
WP2064	Neural crest differentiation	11/675	68/6030	0.133423312005603	0.50643826089959	0.42579666449408	1004/1302/1280/2247/23493/4488/4854/4855/6615/7020/7291	11
WP3927	BMP signaling in eyelid development	4/675	18/6030	0.134120302145019	0.50643826089959	0.42579666449408	2255/2296/6422/6469	4
WP2882	Nuclear receptors meta-pathway	36/675	268/6030	0.138548515772274	0.515089280298979	0.433070157610872	8647/874/6347/6364/1543/1545/1555/1577/1551/2099/3082/3458/3589/3553/55554/23764/89795/3084/5142/5155/9588/5743/5272/1836/154091/6515/29986/160728/11254/23657/8140/5552/27286/7042/7056/84951	36
WP4565	Neural crest cell migration in cancer	7/675	39/6030	0.139221719454766	0.515089280298979	0.433070157610872	1009/2047/2151/4313/4915/8503/7291	7
WP4900	Purinergic signaling	5/675	25/6030	0.140102563712004	0.515089280298979	0.433070157610872	134/5027/53829/9934/5031	5
WP2881	Estrogen receptor pathway	3/675	12/6030	0.142959101099928	0.515089280298979	0.433070157610872	1543/1545/2099	3
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/675	12/6030	0.142959101099928	0.515089280298979	0.433070157610872	55509/1437/6688	3
WP4495	IL-10 anti-inflammatory signaling pathway 	3/675	12/6030	0.142959101099928	0.515089280298979	0.433070157610872	3552/3569/6772	3
WP5130	Th17 cell differentiation pathway	10/675	62/6030	0.149877382682166	0.535925186560472	0.450588303597899	50943/3091/3458/3605/3553/3559/3569/861/9021/6772	10
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5/675	26/6030	0.158478407822356	0.558222451433972	0.469335111932666	9536/5737/5739/5743/6916	5
WP4875	Disruption of postsynaptic signaling by CNV	5/675	26/6030	0.158478407822356	0.558222451433972	0.469335111932666	816/2906/9456/22871/57555	5
WP3646	Hepatitis C and hepatocellular carcinoma	8/675	48/6030	0.162416486061662	0.567856158674846	0.477434816727068	1284/3577/3091/3569/4312/4843/5743/7345	8
WP4298	Acute viral myocarditis	12/675	79/6030	0.168337805222273	0.577206940369928	0.485296647010399	199/834/1232/1604/941/3458/3569/3908/64127/6444/8651/6772	12
WP1434	Osteopontin signaling	3/675	13/6030	0.171205448414809	0.577206940369928	0.485296647010399	3690/5328/6696	3
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3/675	13/6030	0.171205448414809	0.577206940369928	0.485296647010399	249/6422/7015	3
WP3958	GPR40 pathway	3/675	13/6030	0.171205448414809	0.577206940369928	0.485296647010399	23236/5333/113026	3
WP554	ACE inhibitor pathway	3/675	13/6030	0.171205448414809	0.577206940369928	0.485296647010399	1511/3827/4846	3
WP5121	Sphingolipid metabolism in senescence	5/675	27/6030	0.17777187554539	0.585023563616076	0.491868607232963	23236/9294/55512/8877/7015	5
WP167	Eicosanoid synthesis	4/675	20/6030	0.178481765171006	0.585023563616076	0.491868607232963	247/9536/5743/6916	4
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4/675	20/6030	0.178481765171006	0.585023563616076	0.491868607232963	2626/3569/3791/6696	4
WP5044	Kynurenine pathway and links to cell senescence	4/675	20/6030	0.178481765171006	0.585023563616076	0.491868607232963	3620/3458/8942/6999	4
WP364	IL6 signaling pathway	7/675	42/6030	0.183981022621904	0.598889949500266	0.503527009281	3055/3569/639/9021/6772/7076/7432	7
WP2324	AGE/RAGE pathway	10/675	65/6030	0.185934339356442	0.601102795727674	0.50538749774606	249/3091/4322/4323/4313/4316/4481/4843/4846/6772	10
WP4561	Cell migration and invasion through p75NTR	5/675	28/6030	0.197892870923841	0.627851490803688	0.527876922464297	1009/1944/4313/4915/7291	5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	7/675	43/6030	0.200089757173115	0.627851490803688	0.527876922464297	816/2906/116443/9456/4915/8503/85358	7
WP1602	Nicotine effect on dopaminergic neurons	3/675	14/6030	0.200859269303722	0.627851490803688	0.527876922464297	1138/3777/6571	3
WP3935	Leptin-insulin signaling overlap	3/675	14/6030	0.200859269303722	0.627851490803688	0.527876922464297	8503/8651/9021	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/675	14/6030	0.200859269303722	0.627851490803688	0.527876922464297	941/942/8503	3
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/675	21/6030	0.202283093001991	0.628142236164078	0.528121371618772	941/942/3101/6515	4
WP4564	Neural crest cell migration during development	6/675	36/6030	0.209499549556376	0.64629926399091	0.543387204559708	1009/2047/2151/4313/8503/7291	6
WP4018	Clear cell renal cell carcinoma pathways	12/675	83/6030	0.213952218854156	0.655749657786763	0.551332785427318	1012/2321/3091/3101/3759/3791/5155/5159/29968/10993/7042/7043	12
WP2118	Arrhythmogenic right ventricular cardiomyopathy	9/675	60/6030	0.223976129821762	0.682043440489495	0.573439734755887	87/2697/22801/3673/3678/8516/3690/3908/6444	9
WP3591	Sleep regulation	4/675	22/6030	0.226950547812348	0.686670888252744	0.577330340926148	134/3569/22871/4887	4
WP536	Calcium regulation in cardiac cells	17/675	125/6030	0.230793908773314	0.691841268122389	0.581677426588182	147/777/816/2697/2701/2702/2707/127534/10052/59345/2791/51764/5350/64407/5999/8490/8787	17
WP4842	Mammalian disorder of sexual development	3/675	15/6030	0.231590932973173	0.691841268122389	0.581677426588182	10468/2626/30812	3
WP4197	Immune response to tuberculosis	4/675	23/6030	0.25232289817943	0.72885772045553	0.612799644539998	8519/8651/6772/6890	4
WP4483	Relationship between inflammation, COX-2 and EGFR	4/675	23/6030	0.25232289817943	0.72885772045553	0.612799644539998	2099/4312/51365/5743	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/675	23/6030	0.25232289817943	0.72885772045553	0.612799644539998	29126/3458/4776/80380	4
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4/675	23/6030	0.25232289817943	0.72885772045553	0.612799644539998	3553/3569/10135/23057	4
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/675	78/6030	0.252592377856772	0.72885772045553	0.612799644539998	8061/11211/283120/5328/4920/6422/6423/64321/7020/7472/7474	11
WP3942	PPAR signaling pathway	8/675	54/6030	0.253247174056583	0.72885772045553	0.612799644539998	2180/2182/126129/4023/4312/4973/5346/28965	8
WP4241	Type 2 papillary renal cell carcinoma	5/675	31/6030	0.262263872858342	0.750233624176589	0.630771802664082	1513/3091/5155/7042/7043	5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	10/675	72/6030	0.282645794176663	0.803667559345693	0.675697301234002	8061/11211/5328/4920/6422/6423/64321/83595/7472/7474	10
WP4542	Leukocyte-intrinsic Hippo pathway functions	5/675	32/6030	0.284729683755411	0.804744974446431	0.6766031564815	50943/26524/4023/639/7004	5
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	3/675	17/6030	0.295064368002086	0.824085098798725	0.69286369814255	10631/3371/7472	3
WP4784	Proteoglycan biosynthesis	3/675	17/6030	0.295064368002086	0.824085098798725	0.69286369814255	9469/55790/1836	3
WP428	Wnt signaling	13/675	98/6030	0.299965630325769	0.830922018477934	0.698611955767576	816/8061/11211/4776/5328/23236/166336/4920/6422/6423/64321/7472/7474	13
WP4655	Cytosolic DNA-sensing pathway	8/675	57/6030	0.303673630940743	0.830922018477934	0.698611955767576	834/6351/9560/3627/3553/90865/3569/81030	8
WP4950	16p11.2 distal deletion syndrome	4/675	25/6030	0.304554044908226	0.830922018477934	0.698611955767576	1380/8519/3791/5350	4
WP581	EPO receptor signaling	4/675	25/6030	0.304554044908226	0.830922018477934	0.698611955767576	5163/10076/8651/6772	4
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2/675	10/6030	0.310355197577334	0.833329616390898	0.700636185056576	1116/9021	2
WP4846	SARS-CoV-2 and COVID-19 pathway	2/675	10/6030	0.310355197577334	0.833329616390898	0.700636185056576	1514/8829	2
WP4217	Ebola virus infection in host	16/675	124/6030	0.310733077298301	0.833329616390898	0.700636185056576	87/432/684/11314/10332/93978/1514/26762/84868/3673/3678/3690/8503/9021/6772/7020	16
WP3877	MYD88 distinct input-output pathway	3/675	18/6030	0.327253181173499	0.858130563966063	0.721488007616427	3552/7097/51311	3
WP4533	Transcription co-factors SKI and SKIL protein partners	3/675	18/6030	0.327253181173499	0.858130563966063	0.721488007616427	26524/23314/7004	3
WP4760	PKC-gamma calcium signaling pathway in ataxia	3/675	18/6030	0.327253181173499	0.858130563966063	0.721488007616427	2769/5163/23236	3
WP5149	Lipid metabolism in senescent cells	3/675	18/6030	0.327253181173499	0.858130563966063	0.721488007616427	50487/7941/5743	3
WP299	Nuclear receptors in lipid metabolism and toxicity	4/675	26/6030	0.331113251651111	0.863455551266986	0.725965082131253	19/8647/1594/1555	4
WP4658	Small cell lung cancer	12/675	93/6030	0.345674386182989	0.896474232298741	0.753726105211029	1282/1284/2335/3673/284217/3908/3910/3915/10319/4843/8503/5743	12
WP2586	Aryl hydrocarbon receptor pathway	6/675	43/6030	0.348933995865371	0.897593911296971	0.754667494556106	1543/1545/2099/4023/135112/5743	6
WP4947	Nitric oxide metabolism in cystic fibrosis	2/675	11/6030	0.353442655013937	0.897593911296971	0.754667494556106	4843/4846	2
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	2/675	11/6030	0.353442655013937	0.897593911296971	0.754667494556106	2358/5163	2
WP5102	Familial partial lipodystrophy (FPLD)	4/675	27/6030	0.357781317060802	0.897593911296971	0.754667494556106	2624/4023/5346/5396	4
WP3599	Transcription factor regulation in adipogenesis	3/675	19/6030	0.35941790092188	0.897593911296971	0.754667494556106	1051/3569/7291	3
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/675	19/6030	0.35941790092188	0.897593911296971	0.754667494556106	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/675	19/6030	0.35941790092188	0.897593911296971	0.754667494556106	2180/3651/55512	3
WP3945	TYROBP causal network in microglia	8/675	61/6030	0.373760350217443	0.926968896201856	0.779365017547056	3142/10261/3687/10008/4688/5341/6696/7305	8
WP2873	Aryl hydrocarbon receptor pathway	5/675	36/6030	0.377072093370247	0.926968896201856	0.779365017547056	1543/1545/3458/3553/8140	5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5/675	36/6030	0.377072093370247	0.926968896201856	0.779365017547056	684/8519/10581/10410/6196	5
WP3888	VEGFA-VEGFR2 signaling pathway	48/675	409/6030	0.383818989199643	0.92882875948289	0.780928729538469	9510/56999/301/81575/22899/813/6347/1003/79094/2022/2078/24147/2321/2335/6624/2523/2624/2697/3142/5654/3383/3490/3690/3791/9079/4319/4323/4313/79812/4688/91624/4846/4855/8013/8828/5228/5328/5329/9588/5743/57381/27289/6401/6648/6772/7004/8794/81567	48
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/675	28/6030	0.384429391416962	0.92882875948289	0.780928729538469	3082/7042/7043/7474	4
WP4481	Resistin as a regulator of inflammation	4/675	28/6030	0.384429391416962	0.92882875948289	0.780928729538469	3569/23236/5333/113026	4
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	6/675	45/6030	0.390729349536422	0.92882875948289	0.780928729538469	19/2180/2182/9023/54898/3992	6
WP3640	Imatinib and chronic myeloid leukemia	3/675	20/6030	0.391347807230858	0.92882875948289	0.780928729538469	2321/5159/11040	3
WP3645	NAD+ biosynthetic pathways	3/675	20/6030	0.391347807230858	0.92882875948289	0.780928729538469	3620/10135/6999	3
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/675	12/6030	0.395539365796739	0.92882875948289	0.780928729538469	1634/6422	2
WP4211	Transcriptional cascade regulating adipogenesis	2/675	12/6030	0.395539365796739	0.92882875948289	0.780928729538469	1051/2624	2
WP5110	Familial hyperlipidemia type 3	2/675	12/6030	0.395539365796739	0.92882875948289	0.780928729538469	4023/7436	2
WP2876	Pregnane X receptor pathway	4/675	29/6030	0.410938586771813	0.955482822444806	0.803338590681739	1555/1577/1551/27286	4
WP4698	Vitamin D-sensitive calcium signaling in depression	4/675	29/6030	0.410938586771813	0.955482822444806	0.803338590681739	793/1594/2906/3786	4
WP4787	Osteoblast differentiation and related diseases	12/675	98/6030	0.416661279993165	0.964039824297911	0.810533036932008	2255/2247/2252/11211/2737/23493/4854/4855/8503/6772/7472/7474	12
WP383	Striated muscle contraction pathway	3/675	21/6030	0.422858592935669	0.973606126173833	0.81857606950833	59/4604/7134	3
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/675	13/6030	0.436327350775272	0.974117955170052	0.819006398526114	4312/5743	2
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2/675	13/6030	0.436327350775272	0.974117955170052	0.819006398526114	3690/7134	2
WP4942	15q13.3 copy number variation syndrome	2/675	13/6030	0.436327350775272	0.974117955170052	0.819006398526114	1139/871	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/675	13/6030	0.436327350775272	0.974117955170052	0.819006398526114	8647/9420	2
WP143	Fatty acid beta-oxidation	4/675	30/6030	0.437200404199672	0.974117955170052	0.819006398526114	2180/2182/8513/4023	4
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/675	30/6030	0.437200404199672	0.974117955170052	0.819006398526114	3624/6469/6615/7474	4
WP4806	EGFR tyrosine kinase inhibitor resistance	10/675	82/6030	0.437527556135701	0.974117955170052	0.819006398526114	2247/3082/3569/3791/22808/3084/5155/5159/8503/399694	10
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	8/675	65/6030	0.444828872195893	0.981117886338605	0.824891710860068	816/941/9076/1514/3690/4868/5329/7225	8
WP3303	RAC1/PAK1/p38/MMP2 pathway	8/675	65/6030	0.444828872195893	0.981117886338605	0.824891710860068	284/285/2335/4313/4843/7010/7075/79931	8
WP4537	Hippo-Yap signaling pathway	3/675	22/6030	0.453791442165667	0.991618336584235	0.833720144719573	3627/26524/7004	3
WP4595	Urea cycle and associated pathways	3/675	22/6030	0.453791442165667	0.991618336584235	0.833720144719573	4843/4846/5831	3
WP4222	Phosphodiesterases in neuronal function	5/675	40/6030	0.469232765863985	0.999999905597861	0.840767092797488	1139/2906/2977/10846/5142	5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2/675	14/6030	0.47557203102053	0.999999905597861	0.840767092797488	3589/3569	2
WP4584	Biomarkers for pyrimidine metabolism disorders	2/675	14/6030	0.47557203102053	0.999999905597861	0.840767092797488	1152/1890	2
WP47	Hedgehog signaling pathway	2/675	14/6030	0.47557203102053	0.999999905597861	0.840767092797488	2737/6469	2
WP5061	Fatty acid transporters	2/675	14/6030	0.47557203102053	0.999999905597861	0.840767092797488	2180/2182	2
WP58	Monoamine GPCRs	2/675	14/6030	0.47557203102053	0.999999905597861	0.840767092797488	147/3274	2
WP697	Estrogen metabolism	2/675	14/6030	0.47557203102053	0.999999905597861	0.840767092797488	1543/1545	2
WP3845	Canonical and non-canonical Notch signaling	3/675	23/6030	0.484011723763603	0.999999905597861	0.840767092797488	4237/4854/4855	3
WP4545	Oxysterols derived from cholesterol	4/675	32/6030	0.488600819305057	0.999999905597861	0.840767092797488	9023/9420/2099/3605	4
WP2332	Interleukin-11 signaling pathway	5/675	41/6030	0.491686300476376	0.999999905597861	0.840767092797488	3383/3589/3673/9021/6772	5
WP2855	Dopaminergic neurogenesis	2/675	15/6030	0.513107584566277	0.999999905597861	0.840767092797488	6469/6571	2
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2/675	15/6030	0.513107584566277	0.999999905597861	0.840767092797488	1051/23657	2
WP5109	Familial hyperlipidemia type 2	2/675	15/6030	0.513107584566277	0.999999905597861	0.840767092797488	4023/255738	2
WP26	S1P receptor signal transduction	3/675	24/6030	0.513407426027427	0.999999905597861	0.840767092797488	23236/9294/8877	3
WP3529	Zinc homeostasis	4/675	33/6030	0.513575156476595	0.999999905597861	0.840767092797488	4494/4499/55532/29986	4
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/675	52/6030	0.533762308512176	0.999999905597861	0.840767092797488	308/79092/2149/3084/8767/9021	6
WP702	Metapathway biotransformation Phase I and II	14/675	125/6030	0.542104190250926	0.999999905597861	0.840767092797488	1645/9469/1543/1545/56603/1594/1555/1577/1551/9420/2328/64090/90161/4837	14
WP2884	NRF2 pathway	13/675	116/6030	0.542736983672051	0.999999905597861	0.840767092797488	874/3082/23764/3084/5155/9588/154091/6515/29986/160728/11254/23657/7042	13
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/675	80/6030	0.546789475492724	0.999999905597861	0.840767092797488	50506/405753/3690/23236/5346/6469/6567/7068/7253	9
WP3644	NAD+ metabolism	2/675	16/6030	0.548824529176427	0.999999905597861	0.840767092797488	10135/23057	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/675	16/6030	0.548824529176427	0.999999905597861	0.840767092797488	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/675	16/6030	0.548824529176427	0.999999905597861	0.840767092797488	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/675	16/6030	0.548824529176427	0.999999905597861	0.840767092797488	3569/64386	2
WP4970	Galanin receptor pathway	2/675	16/6030	0.548824529176427	0.999999905597861	0.840767092797488	3569/7020	2
WP2359	Parkin-ubiquitin proteasomal system pathway	7/675	62/6030	0.550482130914189	0.999999905597861	0.840767092797488	834/2861/3310/6622/9627/347733/9246	7
WP4657	22q11.2 copy number variation syndrome	10/675	90/6030	0.560317779768168	0.999999905597861	0.840767092797488	59/150209/8854/9076/56603/2255/2296/9464/6469/7450	10
WP241	One-carbon metabolism	3/675	26/6030	0.569379717007931	0.999999905597861	0.840767092797488	10840/2346/219595	3
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3/675	26/6030	0.569379717007931	0.999999905597861	0.840767092797488	5744/6615/6772	3
WP195	IL-1 signaling pathway	6/675	54/6030	0.572153004732677	0.999999905597861	0.840767092797488	6347/3552/3553/3554/3556/11213	6
WP4673	Male infertility	11/675	100/6030	0.572571003435987	0.999999905597861	0.840767092797488	1543/56603/2099/2346/219595/4313/4843/4846/29968/8787/6648	11
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	5/675	45/6030	0.57746165835243	0.999999905597861	0.840767092797488	6356/3055/3559/3569/6772	5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/675	17/6030	0.582659217333006	0.999999905597861	0.840767092797488	87/3690	2
WP5074	Kallmann syndrome	2/675	17/6030	0.582659217333006	0.999999905597861	0.840767092797488	23129/60675	2
WP4249	Hedgehog signaling pathway	4/675	37/6030	0.607183539093019	0.999999905597861	0.840767092797488	91653/2619/2737/6469	4
WP497	Urea cycle and metabolism of amino groups	2/675	18/6030	0.614584971852944	0.999999905597861	0.840767092797488	1152/5831	2
WP5033	Genes associated with the development of rheumatoid arthritis	2/675	18/6030	0.614584971852944	0.999999905597861	0.840767092797488	3559/23569	2
WP286	IL-3 signaling pathway	5/675	47/6030	0.617353661873169	0.999999905597861	0.840767092797488	1232/942/1439/3055/3563	5
WP3925	Amino acid metabolism	8/675	77/6030	0.643265776656344	0.999999905597861	0.840767092797488	127/586/3034/3067/5831/10993/6898/6999	8
WP2895	Differentiation of white and brown adipocyte	2/675	19/6030	0.644604627256598	0.999999905597861	0.840767092797488	1051/253738	2
WP325	Triacylglyceride synthesis	2/675	19/6030	0.644604627256598	0.999999905597861	0.840767092797488	8513/4023	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/675	19/6030	0.644604627256598	0.999999905597861	0.840767092797488	8708/8877	2
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2/675	19/6030	0.644604627256598	0.999999905597861	0.840767092797488	3091/5163	2
WP5194	Synthesis of ceramides and 1-deoxyceramides	2/675	19/6030	0.644604627256598	0.999999905597861	0.840767092797488	53947/8877	2
WP3676	BDNF-TrkB signaling	3/675	29/6030	0.645458179606018	0.999999905597861	0.840767092797488	9456/4915/7225	3
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/675	30/6030	0.668597932428945	0.999999905597861	0.840767092797488	4846/5163/8503	3
WP3580	Methionine de novo and salvage pathway	2/675	20/6030	0.672744273926125	0.999999905597861	0.840767092797488	259307/6898	2
WP4224	Purine metabolism and related disorders	2/675	20/6030	0.672744273926125	0.999999905597861	0.840767092797488	270/316	2
WP2007	Iron metabolism in placenta	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	7018	1
WP3656	Interleukin-1 induced activation of NF-kB	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	3552	1
WP4259	Disorders of folate metabolism and transport	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	8647	1
WP5050	TCA cycle in senescence	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	5163	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	629	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/675	10/6030	0.695201627500697	0.999999905597861	0.840767092797488	51311	1
WP262	Ebstein-Barr virus LMP1 signaling	2/675	21/6030	0.699048029819858	0.999999905597861	0.840767092797488	6364/9260	2
WP4905	1q21.1 copy number variation syndrome	2/675	21/6030	0.699048029819858	0.999999905597861	0.840767092797488	2697/2702	2
WP4963	p53 transcriptional gene network	8/675	81/6030	0.699742632260376	0.999999905597861	0.840767092797488	6347/126129/6376/55332/3383/4688/5054/23657	8
WP357	Fatty acid biosynthesis	2/675	22/6030	0.723573688585277	0.999999905597861	0.840767092797488	2180/2182	2
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	2/675	22/6030	0.723573688585277	0.999999905597861	0.840767092797488	597/5744	2
WP229	Irinotecan pathway	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	1577	1
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	23236	1
WP3871	Valproic acid pathway	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	1555	1
WP3930	EDA signaling in hair follicle development	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	6469	1
WP4271	Vitamin B12 disorders	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	6947	1
WP4583	Biomarkers for urea cycle disorders	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	2155	1
WP4788	Autosomal recessive osteopetrosis pathways	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	29887	1
WP4919	Neuroinflammation	1/675	11/6030	0.729377524749373	0.999999905597861	0.840767092797488	4843	1
WP244	Alpha 6 beta 4 signaling pathway	3/675	33/6030	0.731305293014063	0.999999905597861	0.840767092797488	284217/3908/3915	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	3/675	33/6030	0.731305293014063	0.999999905597861	0.840767092797488	816/9586/1511	3
WP1772	Apoptosis modulation and signaling	8/675	84/6030	0.738127140012366	0.999999905597861	0.840767092797488	597/638/834/8739/3554/4671/5783/8794	8
WP2267	Synaptic vesicle pathway	4/675	44/6030	0.741807116434412	0.999999905597861	0.840767092797488	6571/6507/6812/6853	4
WP34	Ovarian infertility	2/675	23/6030	0.746389113806388	0.999999905597861	0.840767092797488	1051/2701	2
WP4357	NRF2-ARE regulation	2/675	23/6030	0.746389113806388	0.999999905597861	0.840767092797488	1051/23657	2
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	2/675	23/6030	0.746389113806388	0.999999905597861	0.840767092797488	3569/114548	2
WP2023	Cell differentiation - expanded index	1/675	12/6030	0.759726448290522	0.999999905597861	0.840767092797488	10637	1
WP4792	Purine metabolism	1/675	12/6030	0.759726448290522	0.999999905597861	0.840767092797488	270	1
WP5112	Familial hyperlipidemia type 5	1/675	12/6030	0.759726448290522	0.999999905597861	0.840767092797488	4023	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	2/675	24/6030	0.767569267240839	0.999999905597861	0.840767092797488	247/2358	2
WP4925	Unfolded protein response	2/675	24/6030	0.767569267240839	0.999999905597861	0.840767092797488	3553/7494	2
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	2/675	24/6030	0.767569267240839	0.999999905597861	0.840767092797488	2769/23236	2
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4/675	46/6030	0.773093791189132	0.999999905597861	0.840767092797488	5163/8503/11040/6196	4
WP61	Notch signaling pathway	5/675	57/6030	0.780392564839928	0.999999905597861	0.840767092797488	1840/23493/3091/4854/4855	5
WP2289	Drug induction of bile acid pathway	1/675	13/6030	0.786676373083459	0.999999905597861	0.840767092797488	8647	1
WP3853	ERK pathway in Huntington's disease	1/675	13/6030	0.786676373083459	0.999999905597861	0.840767092797488	4915	1
WP5108	Familial  hyperlipidemia type 1	1/675	13/6030	0.786676373083459	0.999999905597861	0.840767092797488	4023	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/675	13/6030	0.786676373083459	0.999999905597861	0.840767092797488	3091	1
WP1528	Physiological and pathological hypertrophy of the heart	2/675	25/6030	0.78719377460581	0.999999905597861	0.840767092797488	2626/4776	2
WP205	IL-7 signaling pathway	2/675	25/6030	0.78719377460581	0.999999905597861	0.840767092797488	3559/6772	2
WP3613	Photodynamic therapy-induced unfolded protein response	2/675	25/6030	0.78719377460581	0.999999905597861	0.840767092797488	121506/7494	2
WP430	Statin inhibition of cholesterol production	2/675	25/6030	0.78719377460581	0.999999905597861	0.840767092797488	19/4023	2
WP1403	AMP-activated protein kinase (AMPK) signaling	5/675	58/6030	0.793270195015088	0.999999905597861	0.840767092797488	147/126129/5209/8503/23236	5
WP4262	Breast cancer pathway	12/675	129/6030	0.793713590040142	0.999999905597861	0.840767092797488	2099/2255/2247/2252/11211/23493/4854/4855/8503/399694/7472/7474	12
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2/675	26/6030	0.805344946072299	0.999999905597861	0.840767092797488	1051/2099	2
WP3851	TLR4 signaling and tolerance	2/675	26/6030	0.805344946072299	0.999999905597861	0.840767092797488	3569/11213	2
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/675	26/6030	0.805344946072299	0.999999905597861	0.840767092797488	4915/8503	2
WP2879	Farnesoid X receptor pathway	1/675	14/6030	0.810607476319069	0.999999905597861	0.840767092797488	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/675	14/6030	0.810607476319069	0.999999905597861	0.840767092797488	283120	1
WP3611	Photodynamic therapy-induced AP-1 survival signaling	4/675	49/6030	0.814332641945734	0.999999905597861	0.840767092797488	2252/3458/3569/4313	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4/675	49/6030	0.814332641945734	0.999999905597861	0.840767092797488	1051/1513/6696/7042	4
WP4758	Nephrotic syndrome	3/675	38/6030	0.814582449175114	0.999999905597861	0.840767092797488	8542/4868/7225	3
WP5098	T-cell activation SARS-CoV-2	7/675	81/6030	0.817134356307939	0.999999905597861	0.840767092797488	941/942/3458/3595/3605/8809/3937	7
WP2112	IL-17 signaling pathway	2/675	27/6030	0.822106180397978	0.999999905597861	0.840767092797488	1051/3605	2
WP2643	Nanoparticle-mediated activation of receptor signaling	2/675	27/6030	0.822106180397978	0.999999905597861	0.840767092797488	1277/2335	2
WP2875	Constitutive androstane receptor pathway	2/675	27/6030	0.822106180397978	0.999999905597861	0.840767092797488	1555/1577	2
WP2526	PDGF pathway	3/675	39/6030	0.828328429354743	0.999999905597861	0.840767092797488	5155/5159/6772	3
WP2828	Bladder cancer	3/675	39/6030	0.828328429354743	0.999999905597861	0.840767092797488	4312/4313/1890	3
WP4313	Ferroptosis	5/675	61/6030	0.82836853532012	0.999999905597861	0.840767092797488	2180/2182/1645/23657/7018	5
WP4962	Airway smooth muscle cell contraction	1/675	15/6030	0.831857468587126	0.999999905597861	0.840767092797488	23236	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/675	15/6030	0.831857468587126	0.999999905597861	0.840767092797488	3091	1
WP4150	Wnt signaling in kidney disease	2/675	28/6030	0.837560691807711	0.999999905597861	0.840767092797488	7472/7474	2
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/675	28/6030	0.837560691807711	0.999999905597861	0.840767092797488	59/9104	2
WP5224	2q37 copy number variation syndrome	9/675	104/6030	0.838059617105341	0.999999905597861	0.840767092797488	19/10203/1293/6373/64090/3553/3690/129807/3651	9
WP3940	One-carbon metabolism and related pathways	3/675	40/6030	0.84119222899313	0.999999905597861	0.840767092797488	586/23743/6648	3
WP4312	Rett syndrome causing genes	3/675	40/6030	0.84119222899313	0.999999905597861	0.840767092797488	23314/85358/6812	3
WP395	IL-4 signaling pathway	4/675	52/6030	0.849222383523125	0.999999905597861	0.840767092797488	1051/8651/9021/6772	4
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1/675	16/6030	0.850726331214506	0.999999905597861	0.840767092797488	19	1
WP22	IL-9 signaling pathway	1/675	16/6030	0.850726331214506	0.999999905597861	0.840767092797488	6772	1
WP4225	Pyrimidine metabolism and related diseases	1/675	16/6030	0.850726331214506	0.999999905597861	0.840767092797488	1890	1
WP3972	PDGFR-beta pathway	2/675	29/6030	0.851790507526355	0.999999905597861	0.840767092797488	5159/6772	2
WP408	Oxidative stress response	2/675	29/6030	0.851790507526355	0.999999905597861	0.840767092797488	1543/6648	2
WP268	Notch signaling	3/675	41/6030	0.853213964601063	0.999999905597861	0.840767092797488	1840/4854/4855	3
WP4290	Metabolic reprogramming in colon cancer	3/675	41/6030	0.853213964601063	0.999999905597861	0.840767092797488	3101/29968/5831	3
WP49	IL-2 signaling pathway	3/675	41/6030	0.853213964601063	0.999999905597861	0.840767092797488	3559/9021/6772	3
WP2034	Leptin signaling pathway	6/675	75/6030	0.859496666643878	0.999999905597861	0.840767092797488	2099/3553/3557/4846/9021/6772	6
WP69	T-cell receptor signaling pathway	7/675	86/6030	0.861748347158055	0.999999905597861	0.840767092797488	3601/3605/3552/3553/3569/3937/8767	7
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3/675	42/6030	0.86443411734829	0.999999905597861	0.840767092797488	59/3690/7004	3
WP4917	Proximal tubule transport	3/675	42/6030	0.86443411734829	0.999999905597861	0.840767092797488	760/762/160728	3
WP3858	Toll-like receptor signaling related to MyD88	2/675	30/6030	0.864875691461884	0.999999905597861	0.840767092797488	7097/51311	2
WP4149	White fat cell differentiation	2/675	30/6030	0.864875691461884	0.999999905597861	0.840767092797488	1051/2624	2
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2/675	30/6030	0.864875691461884	0.999999905597861	0.840767092797488	6772/7097	2
WP2853	Endoderm differentiation	10/675	118/6030	0.865223979430943	0.999999905597861	0.840767092797488	1846/2626/3227/3915/5744/6422/154091/64321/83595/6772	10
WP4912	SARS coronavirus and innate immunity	1/675	17/6030	0.867480525832099	0.999999905597861	0.840767092797488	6772	1
WP5111	Familial hyperlipidemia type 4	1/675	17/6030	0.867480525832099	0.999999905597861	0.840767092797488	4023	1
WP5200	Dravet syndrome	1/675	17/6030	0.867480525832099	0.999999905597861	0.840767092797488	6324	1
WP2018	RANKL/RANK signaling pathway	4/675	54/6030	0.869268717913688	0.999999905597861	0.840767092797488	1513/3383/6688/6772	4
WP399	Wnt signaling pathway and pluripotency	7/675	87/6030	0.869513347048216	0.999999905597861	0.840767092797488	8061/11211/120892/4316/5328/7472/7474	7
WP1971	Integrated cancer pathway	3/675	43/6030	0.874893143501341	0.999999905597861	0.840767092797488	994/4312/6772	3
WP366	TGF-beta signaling pathway	11/675	130/6030	0.875660258439482	0.999999905597861	0.840767092797488	1278/2335/2354/50943/3673/3690/4312/4321/5163/7015/3371	11
WP4223	Ras signaling	14/675	161/6030	0.876659671668979	0.999999905597861	0.840767092797488	2321/59345/2791/51764/3791/22808/4915/5159/8503/51365/50487/115727/399694/7010	14
WP4844	Influence of laminopathies on Wnt signaling	2/675	31/6030	0.876893756086809	0.999999905597861	0.840767092797488	1051/6696	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/675	31/6030	0.876893756086809	0.999999905597861	0.840767092797488	5163/23236	2
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/675	18/6030	0.882356734889697	0.999999905597861	0.840767092797488	22808	1
WP4971	Phosphoinositides metabolism	3/675	44/6030	0.884631145481848	0.999999905597861	0.840767092797488	23236/5333/113026	3
WP3298	Melatonin metabolism and effects	2/675	32/6030	0.887919230210068	0.999999905597861	0.840767092797488	1543/1545	2
WP1584	Type II diabetes mellitus	1/675	19/6030	0.895565185313758	0.999999905597861	0.840767092797488	3651	1
WP5103	Progeria-associated lipodystrophy	1/675	19/6030	0.895565185313758	0.999999905597861	0.840767092797488	2200	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/675	19/6030	0.895565185313758	0.999999905597861	0.840767092797488	2626	1
WP3931	Embryonic stem cell pluripotency pathways	7/675	91/6030	0.897059869851976	0.999999905597861	0.840767092797488	2255/2247/2252/5155/5159/7472/7474	7
WP1544	MicroRNAs in cardiomyocyte hypertrophy	6/675	80/6030	0.897217396461222	0.999999905597861	0.840767092797488	2247/2626/4776/3084/8503/7474	6
WP3981	miRNA regulation of prostate cancer signaling pathways	2/675	33/6030	0.898023355190455	0.999999905597861	0.840767092797488	354/5159	2
WP710	DNA damage response (only ATM dependent)	8/675	103/6030	0.903574434888105	0.999999905597861	0.840767092797488	638/8061/5163/8503/5328/6648/7472/7474	8
WP170	Nuclear receptors	2/675	34/6030	0.907273886320886	0.999999905597861	0.840767092797488	2099/7068	2
WP400	p38 MAPK signaling pathway	2/675	34/6030	0.907273886320886	0.999999905597861	0.840767092797488	6772/7042	2
WP2878	PPAR-alpha pathway	1/675	20/6030	0.90729260170258	0.999999905597861	0.840767092797488	55554	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/675	20/6030	0.90729260170258	0.999999905597861	0.840767092797488	3002	1
WP4725	Sphingolipid metabolism overview	1/675	20/6030	0.90729260170258	0.999999905597861	0.840767092797488	8877	1
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4/675	59/6030	0.909617363524037	0.999999905597861	0.840767092797488	1437/3458/3937/5163	4
WP382	MAPK signaling pathway	18/675	210/6030	0.913695004468895	0.999999905597861	0.840767092797488	777/994/1846/2255/2247/2252/3310/3552/3553/3554/120892/22808/4915/5155/5159/115727/7042/7043	18
WP185	Integrin-mediated cell adhesion	7/675	94/6030	0.914342037960465	0.999999905597861	0.840767092797488	11131/22801/3673/3678/8516/3687/3690	7
WP51	Regulation of actin cytoskeleton	10/675	127/6030	0.915826970501338	0.999999905597861	0.840767092797488	87/2149/2255/2247/2252/2335/22808/5155/5159/8503	10
WP4288	MTHFR deficiency	1/675	21/6030	0.917704830296717	0.999999905597861	0.840767092797488	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/675	21/6030	0.917704830296717	0.999999905597861	0.840767092797488	8877	1
WP4630	Measles virus infection	9/675	117/6030	0.919492860125938	0.999999905597861	0.840767092797488	10332/3310/3552/3553/3559/3569/8503/6772/7097	9
WP2447	Amyotrophic lateral sclerosis (ALS)	2/675	36/6030	0.923467147998764	0.999999905597861	0.840767092797488	834/4741	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/675	36/6030	0.923467147998764	0.999999905597861	0.840767092797488	3488/5163	2
WP623	Oxidative phosphorylation	2/675	36/6030	0.923467147998764	0.999999905597861	0.840767092797488	3002/56901	2
WP2272	Pathogenic Escherichia coli infection	3/675	49/6030	0.923853900139472	0.999999905597861	0.840767092797488	9076/23643/347733	3
WP2637	Interleukin-1 (IL-1) structural pathway	3/675	49/6030	0.923853900139472	0.999999905597861	0.840767092797488	3552/3554/3556	3
WP363	Wnt signaling pathway	3/675	49/6030	0.923853900139472	0.999999905597861	0.840767092797488	2697/4920/7010	3
WP4482	Vitamin D in inflammatory diseases	1/675	22/6030	0.926949170378214	0.999999905597861	0.840767092797488	3569	1
WP4686	Leucine, isoleucine and valine metabolism	1/675	22/6030	0.926949170378214	0.999999905597861	0.840767092797488	586	1
WP712	Estrogen signaling pathway	1/675	22/6030	0.926949170378214	0.999999905597861	0.840767092797488	2099	1
WP4932	7q11.23 copy number variation syndrome	6/675	86/6030	0.930739616735212	0.999999905597861	0.840767092797488	9076/2199/2200/3084/9246/7472	6
WP2037	Prolactin signaling pathway	5/675	75/6030	0.9337027940278	0.999999905597861	0.840767092797488	4843/6196/8651/9021/6772	5
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/675	23/6030	0.935156445676933	0.999999905597861	0.840767092797488	5054	1
WP5064	7-oxo-C and 7-beta-HC pathways	1/675	23/6030	0.935156445676933	0.999999905597861	0.840767092797488	3290	1
WP3286	Copper homeostasis	3/675	51/6030	0.935796625338023	0.999999905597861	0.840767092797488	4494/26872/79689	3
WP500	Glycogen synthesis and degradation	2/675	38/6030	0.936968650120634	0.999999905597861	0.840767092797488	3101/5255	2
WP4906	3q29 copy number variation syndrome	3/675	52/6030	0.941097089122609	0.999999905597861	0.840767092797488	3091/8503/7018	3
WP127	IL-5 signaling pathway	2/675	39/6030	0.942841094486358	0.999999905597861	0.840767092797488	1439/6772	2
WP534	Glycolysis and gluconeogenesis	2/675	39/6030	0.942841094486358	0.999999905597861	0.840767092797488	3101/6515	2
WP4549	Fragile X syndrome	7/675	101/6030	0.945231733525642	0.999999905597861	0.840767092797488	816/80852/9456/4131/4915/5163/23236	7
WP585	Interferon type I signaling pathways	3/675	53/6030	0.945989901313082	0.999999905597861	0.840767092797488	8651/9021/6772	3
WP2355	Corticotropin-releasing hormone signaling pathway	5/675	78/6030	0.9467521103752	0.999999905597861	0.840767092797488	2354/8061/2697/4846/7020	5
WP3965	Lipid metabolism pathway	1/675	25/6030	0.948911555994937	0.999999905597861	0.840767092797488	5346	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	2/675	41/6030	0.953061653758778	0.999999905597861	0.840767092797488	3552/8767	2
WP1422	Sphingolipid pathway	1/675	26/6030	0.954654220391842	0.999999905597861	0.840767092797488	8877	1
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2/675	42/6030	0.957493030579302	0.999999905597861	0.840767092797488	6347/3569	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/675	42/6030	0.957493030579302	0.999999905597861	0.840767092797488	7042/7043	2
WP2525	Trans-sulfuration and one-carbon metabolism	1/675	27/6030	0.959752221930068	0.999999905597861	0.840767092797488	29968	1
WP3869	Cannabinoid receptor signaling	1/675	27/6030	0.959752221930068	0.999999905597861	0.840767092797488	1543	1
WP3996	Ethanol effects on histone modifications	1/675	27/6030	0.959752221930068	0.999999905597861	0.840767092797488	8854	1
WP4204	Tumor suppressor activity of SMARCB1	1/675	27/6030	0.959752221930068	0.999999905597861	0.840767092797488	2737	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/675	27/6030	0.959752221930068	0.999999905597861	0.840767092797488	1514	1
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	4/675	70/6030	0.961969109509787	0.999999905597861	0.840767092797488	9423/5743/7042/7043	4
WP673	ErbB signaling pathway	5/675	83/6030	0.963426869079275	0.999999905597861	0.840767092797488	816/3084/145957/8503/399694	5
WP2583	T cell receptor and co-stimulatory signaling	1/675	28/6030	0.964277834156822	0.999999905597861	0.840767092797488	5163	1
WP4255	Non-small cell lung cancer	4/675	71/6030	0.964958790540564	0.999999905597861	0.840767092797488	1381/1382/5163/8503	4
WP5205	Clock-controlled autophagy in bone metabolism	4/675	71/6030	0.964958790540564	0.999999905597861	0.840767092797488	115908/1513/3569/7474	4
WP2038	Microtubule cytoskeleton regulation	2/675	44/6030	0.965183776596057	0.999999905597861	0.840767092797488	2151/4131	2
WP410	Exercise-induced circadian regulation	2/675	44/6030	0.965183776596057	0.999999905597861	0.840767092797488	1051/50486	2
WP3680	Physico-chemical features and toxicity-associated pathways	3/675	58/6030	0.965262766161751	0.999999905597861	0.840767092797488	2335/11211/4741	3
WP5180	DYRK1A	3/675	58/6030	0.965262766161751	0.999999905597861	0.840767092797488	273/2247/26524	3
WP4659	Gastrin signaling pathway	7/675	108/6030	0.965800994065342	0.999999905597861	0.840767092797488	9076/3067/4316/8503/5743/5054/7032	7
WP183	Proteasome degradation	3/675	59/6030	0.968243769874486	0.999999905597861	0.840767092797488	3458/5698/7345	3
WP304	Kit receptor signaling pathway	3/675	59/6030	0.968243769874486	0.999999905597861	0.840767092797488	6615/8651/6772	3
WP1601	Fluoropyrimidine activity	1/675	29/6030	0.968295238679339	0.999999905597861	0.840767092797488	1890	1
WP4321	Thermogenesis	6/675	98/6030	0.970265323152588	0.999999905597861	0.840767092797488	2180/2182/126129/9586/5346/6196	6
WP3594	Circadian rhythm genes	11/675	159/6030	0.974934590220182	0.999999905597861	0.840767092797488	134/56938/2155/9456/3569/10135/22871/4843/4887/60675/5054	11
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/675	31/6030	0.975027019091895	0.999999905597861	0.840767092797488	4776	1
WP4396	Nonalcoholic fatty liver disease	9/675	137/6030	0.976437565588892	0.999999905597861	0.840767092797488	6347/84701/3552/3553/3569/56901/8503/9021/7494	9
WP3995	Prion disease pathway	1/675	32/6030	0.977836947765503	0.999999905597861	0.840767092797488	6688	1
WP3998	Prader-Willi and Angelman syndrome	1/675	32/6030	0.977836947765503	0.999999905597861	0.840767092797488	4948	1
WP2059	Alzheimer's disease and miRNA effects	17/675	229/6030	0.979329948868162	0.999999905597861	0.840767092797488	1139/11211/2906/3552/3553/3569/4023/407024/4843/8503/23236/5743/6622/347733/7472/7474/7494	17
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3/675	64/6030	0.979855873195831	0.999999905597861	0.840767092797488	23236/6772/7253	3
WP4874	CAMKK2 pathway	1/675	33/6030	0.980331122533473	0.999999905597861	0.840767092797488	3383	1
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	1/675	33/6030	0.980331122533473	0.999999905597861	0.840767092797488	6772	1
WP313	Hepatocyte growth factor receptor signaling	1/675	34/6030	0.982544978176279	0.999999905597861	0.840767092797488	3082	1
WP4949	16p11.2 proximal deletion syndrome	3/675	67/6030	0.984744301168976	0.999999905597861	0.840767092797488	253982/2099/653808	3
WP2795	Cardiac hypertrophic response	2/675	53/6030	0.986070533528639	0.999999905597861	0.840767092797488	2247/3084	2
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	2/675	53/6030	0.986070533528639	0.999999905597861	0.840767092797488	3627/3458	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/675	53/6030	0.986070533528639	0.999999905597861	0.840767092797488	3082/8503	2
WP2857	Mesodermal commitment pathway	7/675	121/6030	0.986502023566322	0.999999905597861	0.840767092797488	2296/3624/10637/4211/154091/6615/64321	7
WP5124	Alzheimer's disease	16/675	226/6030	0.986711053357273	0.999999905597861	0.840767092797488	1139/11211/2906/3552/3553/3569/4023/4843/8503/23236/5743/6622/347733/7472/7474/7494	16
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	8/675	134/6030	0.987190211111706	0.999999905597861	0.840767092797488	249/4688/4776/4915/399694/6696/6772/6853	8
WP4666	Hepatitis B infection	8/675	134/6030	0.987190211111706	0.999999905597861	0.840767092797488	9586/3569/4776/8503/6772/7042/7043/7097	8
WP2516	ATM signaling pathway	1/675	37/6030	0.987802025322041	0.999999905597861	0.840767092797488	8120	1
WP4148	Splicing factor NOVA regulated synaptic proteins	1/675	37/6030	0.987802025322041	0.999999905597861	0.840767092797488	2898	1
WP35	G protein signaling pathways	4/675	85/6030	0.989361410031181	0.999999905597861	0.840767092797488	2769/2791/51764/5142	4
WP3584	MECP2 and associated Rett syndrome	2/675	56/6030	0.989793193949444	0.999999905597861	0.840767092797488	2247/6890	2
WP5085	Vasopressin-regulated water reabsorption	1/675	39/6030	0.990395237323303	0.999999905597861	0.840767092797488	9586	1
WP4263	Pancreatic adenocarcinoma pathway	4/675	87/6030	0.991082717462954	0.999999905597861	0.840767092797488	8503/6772/7042/7043	4
WP5220	Metabolic reprogramming in pancreatic cancer	1/675	41/6030	0.992437789928097	0.999999905597861	0.840767092797488	8140	1
WP5072	Modulators of TCR signaling and T cell activation	2/675	59/6030	0.99253886076766	0.999999905597861	0.840767092797488	3937/8651	2
WP481	Insulin signaling	9/675	156/6030	0.993629436591343	0.999999905597861	0.840767092797488	30846/8503/57381/6196/10110/8651/9021/6812/7494	9
WP4155	Endometrial cancer	2/675	61/6030	0.993952915702713	0.999999905597861	0.840767092797488	2247/8503	2
WP437	EGF/EGFR signaling pathway	9/675	157/6030	0.994072629335799	0.999999905597861	0.840767092797488	54206/2354/2697/4846/7837/6196/6772/6812/7291	9
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/675	44/6030	0.994717703109741	0.999999905597861	0.840767092797488	7494	1
WP4685	Melanoma	2/675	63/6030	0.995103516830771	0.999999905597861	0.840767092797488	3791/8503	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	6/675	125/6030	0.996423925749381	0.999999905597861	0.840767092797488	1555/4023/8503/6196/6567/7068	6
WP254	Apoptosis	3/675	84/6030	0.997015980746863	0.999999905597861	0.840767092797488	834/3002/8739	3
WP4656	Joubert syndrome	2/675	71/6030	0.997912659831097	0.999999905597861	0.840767092797488	27077/6469	2
WP231	TNF-alpha signaling pathway	3/675	92/6030	0.998652643083193	0.999999905597861	0.840767092797488	6347/3569/6401	3
WP3651	Pathways affected in adenoid cystic carcinoma	1/675	58/6030	0.999012501141449	0.999999905597861	0.840767092797488	4603	1
WP2261	Glioblastoma signaling pathways	2/675	82/6030	0.99936566249272	0.999999905597861	0.840767092797488	54206/5159	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/675	66/6030	0.999621942127052	0.999999905597861	0.840767092797488	4023	1
WP4536	Genes related to primary cilium development (based on CRISPR)	2/675	88/6030	0.999671269372955	0.999999905597861	0.840767092797488	27077/23552	2
WP4674	Head and neck squamous cell carcinoma	1/675	72/6030	0.999816162380803	0.999999905597861	0.840767092797488	7015	1
WP179	Cell cycle	3/675	115/6030	0.999872588992701	0.999999905597861	0.840767092797488	994/7042/7043	3
WP4022	Pyrimidine metabolism	1/675	79/6030	0.999920804694697	0.999999905597861	0.840767092797488	1890	1
WP138	Androgen receptor signaling pathway	1/675	85/6030	0.999961554252024	0.999999905597861	0.840767092797488	354	1
WP2446	Retinoblastoma gene in cancer	1/675	86/6030	0.999965919412644	0.999999905597861	0.840767092797488	994	1
WP477	Cytoplasmic ribosomal proteins	1/675	86/6030	0.999965919412644	0.999999905597861	0.840767092797488	6196	1
WP4803	Ciliopathies	3/675	138/6030	0.99998890303036	0.999999905597861	0.840767092797488	27077/10309/2737	3
WP23	B cell receptor signaling pathway	1/675	96/6030	0.999989800488642	0.999999905597861	0.840767092797488	1380	1
WP4352	Ciliary landscape	4/675	201/6030	0.999999905597861	0.999999905597861	0.840767092797488	3934/4741/7020/7022	4
